EZR and breast carcinoma: By profiling of primary breast tumors, tumor associated normal tissue and breast cancer cell lines using RQ-PCR, as well as functional assays, it was demonstrated that miR-183 targets ezrin and may play a central role in the regulation of migration and metastasis in breast cancer [64].